GlassScriptPhysician profile
Ganxin Yan
NPI 1467457150
$4,657.07
in general payments reported to CMS, 2019-2025
17 companies · $232 in 2025
The $232 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,431 · 2020: $47.80 · 2021: $2,029 · 2022: $125 · 2023: $214 · 2024: $578 · 2025: $232.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,024.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,024.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $2,125.00 | 2021-2022 | |
| Biotronik INC. | $1,367.16 | 2019-2024 | Amvia Edge, Acticor 7 Vr-T Dx |
| Boston Scientific Corporation | $295.15 | 2021-2025 | Ingevity+, Farapulse |
| Impulse Dynamics (USA) INC. | $143.34 | 2025 | Optimizer |
| Gilead Sciences, INC. | $125.00 | 2023 | Vemlidy |
| Merck Sharp & Dohme LLC | $120.82 | 2019 | |
| Allergan, INC. | $117.28 | 2019 | |
| Shockwave Medical, INC | $105.98 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Medtronic, INC. | $101.19 | 2024 | Cobalt Dr Mri Surescan |
| Novartis Pharmaceuticals Corporation | $34.78 | 2019 | |
| Medtronic Vascular, INC. | $23.88 | 2020 | |
| Abbott Laboratories | $22.90 | 2020-2021 | |
| Astrazeneca Pharmaceuticals LP | $16.49 | 2025 | Farxiga |
| Bayer Healthcare Pharmaceuticals INC. | $15.52 | 2025 | |
| Amgen INC. | $14.64 | 2025 | Repatha |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $14.25 | 2025 | Qdot Micro |
| Pfizer INC. | $13.69 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ganxin Yan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.